1/28
Comprehensive vocabulary review flashcards covering next-generation sequencing technologies, clinical diagnostic applications, library preparation workflows, and bioinformatic pipelines as presented by Dr Sarah Beecroft.
Monogenic disease
A genetic condition caused by a mutation in a single gene, frequently investigated in inherited neuromuscular disorders.
Neuromuscular disorders (prevalence)
A group of genetic diseases with an estimated prevalence of ∼1/3000, exhibiting disease onset ranging from in utero to late adulthood and severities ranging from mild to devastating.
Massively parallel sequencing
Another designation for next-generation sequencing (NGS), characterized by executing millions of sequencing reactions simultaneously rather than the single reaction performed in Sanger sequencing.
Whole Genome Sequencing (WGS)
An NGS method that sequences all coding and non-coding regions of the genome, detecting variant types inaccessible to other assays, although non-coding variants remain difficult to clinically interpret.
Whole Exome Sequencing (WES)
An NGS method that targets the protein-coding regions of the genome, accounting for approximately 1–2% of the human genome while harboring approximately 85% of known Mendelian disease variants.
Targeted panel
An NGS assay restricted to specific preselected genes of interest, predominantly utilized for routine diagnostics such as tumor sequencing, eye diseases, and cardiovascular conditions.

DNA scoring metric
A five-point quality control scoring standard (0 to 4) based on gel electrophoresis run against an 850bp ladder marker to assess sample integrity before sequencing.
Score 0 (DNA quality control)
A grade on the DNA scoring metric denoting that there is no smear covering the high-molecular-weight area or no discernible DNA present on the gel.
Score 4 (DNA quality control)
A grade on the DNA scoring metric characterized by a intact high-molecular-weight band with very limited or no smearing.
Fragmentation (NGS Step 2)
The controlled physical or enzymatic process of shearing intact genomic DNA into fragments approximately 200bp in length.
End repair (NGS Step 3)
The enzymatic conversion of sticky, non-blunt ends on sheared DNA fragments followed by denaturation to yield single-stranded DNA.
Target enrichment (NGS Step 4)
The step in targeted sequencing or exome sequencing that selects and isolates specific regions of interest from the bulk genomic DNA library.
Baits (probes)
Short synthetic DNA oligonucleotides engineered to be the reverse complement of target genomic sequences (e.g., 5′-TGTAATC-3′ targeting 5′-GATTACA-3′) tagged with affinity molecules such as biotin.
Hybridisation capture
A target enrichment strategy where biotin-tagged probes hybridize to complementary single-stranded DNA library fragments in solution.

Streptavidin-coated magnetic beads
Microscopic magnetic beads that bind tightly to the biotin tags on probe-DNA hybrids, enabling pull-down with a magnetic rack and washing away of unbound genomic fragments.
Sequencing adaptors
Short synthetic DNA duplexes ligated onto library fragment ends that enable binding to emulsion PCR beads during subsequent clonal amplification.
Barcode adaptors
Specialized adaptor sequences containing unique sample-identifying index tags that allow multiple patient libraries to be pooled and sequenced together (multiplexing).
Emulsion PCR (emPCR)
A clonal amplification method where aqueous droplets suspended in oil act as independent microreactors, each containing PCR reagents, a single magnetic bead, and a single DNA template fragment.
Sequencing by synthesis
A sequencing paradigm where complementary nucleotides are detected and recorded in real time as DNA polymerase incorporates each dNTP along the template strand.
IonProton sequencing mechanism
A semiconductor-based sequencing-by-synthesis method that registers the release of hydrogen ions (H+) during nucleotide incorporation as a change in pH, converted directly into an electrical voltage signal.

Homopolymer error
A sequencing error inherent to pH-sensing platforms where multiple identical consecutive bases (e.g., AA or GGGG) produce a cumulative H+ signal that makes distinguishing exact copy numbers (such as 2 vs 3+ additions) difficult.
Reads
The short fragments of generated nucleotide sequence data that constitute the fundamental output and currency of high-throughput genomics.
Alignment (NGS Step 8)
The bioinformatic mapping of individual short sequencing reads back onto a known reference genome sequence to establish a continuous sequence and identify non-reference bases.
Variant Call Format (VCF)
The standard computational file format used to store identified sequence differences, positions, and associated quality scores relative to the reference genome.
Heterozygous variant calling threshold
The variant calling rule in which an alternate allele is classified as heterozygous when it constitutes between >20% and 80% of total reads covering that position.
Homozygous variant calling threshold
The variant calling rule where an alternate allele is classified as homozygous for the variant when it accounts for >80% of all reads at that genomic site.
Annotation (NGS Step 10)
The computational step of adding biological details to raw variants, such as gene symbols, mutation type (synonymous, missense, frameshift), transcript IDs, and amino acid alterations.
Variant filtering (NGS Step 11)
The analytical procedure of eliminating common background single nucleotide polymorphisms (SNPs) and irrelevant variations using population databases to identify causative disease mutations.
GC-rich and repeat regions
Genomic sequence compositions that represent a prominent technical limitation of NGS platforms, frequently resulting in low sequencing efficiency, dropped coverage, or missing data.